A feasibility study using quantitative and interpretable histological analyses of celiac disease for automated cell

Michael Griffin1, Aaron M Gruver2, Chintan Shah1

  • 1PathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.

Scientific Reports
|December 2, 2024
PubMed

Related Concept Videos